Hypoxia and cardiovascular comorbidity in the ESADA OSA patients with insomnia symptoms

U. Anttalainen (Turku, Finland), J. Hedner (Gothenburg, Sweden), S. Ryan (Dublin, Ireland), R. Riha (Edinburh, United Kingdom), I. Fietze (Berlin, Germany), R. Staats (Lisbon, Portugal), L. Grote (Gothenburg, Sweden), T. Saaresranta (Turku, Finland)

Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Disease area: Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Anttalainen (Turku, Finland), J. Hedner (Gothenburg, Sweden), S. Ryan (Dublin, Ireland), R. Riha (Edinburh, United Kingdom), I. Fietze (Berlin, Germany), R. Staats (Lisbon, Portugal), L. Grote (Gothenburg, Sweden), T. Saaresranta (Turku, Finland). Hypoxia and cardiovascular comorbidity in the ESADA OSA patients with insomnia symptoms. 4962

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
OSAS and the incidence of cardiovascular disorders
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

Prevalence of depressive symptoms in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009


The effects of obstructive sleep apnea on cardiovascular functioning in children with obesity
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013

GERD and anxiety in patients with severe COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

Prevalence of anxiety disorder and depression in newly diagnosed obstructive sleep apnea patients
Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea
Year: 2016


Sleep disturbances, psychological conditions and severity symptoms during hospitalization due to AECOPD
Source: International Congress 2017 – Airway clearance techniques and respiratory physiotherapy in hospitalized patients
Year: 2017

Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 453s
Year: 2007

The analysis of depression symptoms in patients with sleep apnoea syndrome
Source: Eur Respir J 2001; 18: Suppl. 33, 254s
Year: 2001

Sleep disturbances in COPD patients
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010


Sleep disorders in COPD and complex chronic comorbidities
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006



Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
Source: Eur Respir J 2006; 28: Suppl. 50, 413s
Year: 2006

Anxiety, depression and alexithymia in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities
Year: 2011

Sleep disturbance in patients with severe COPD
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010


Sleep-related breathing disorders: impact on mortality of cerebrovascular disease
Source: Eur Respir J 2004; 24: 267-272
Year: 2004



A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016

Cardiovascular comorbidity in severe COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

The diagnostic value of self-reported symptoms for the detection of sleep apnea syndrome in stroke patients
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012


Nocturnal respiratory failure in moderate sleep apnoea as predictive factor of cardiovascular and metabolic comorbidities
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018

The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 198s
Year: 2006